Net Cash Provided by (Used in) Financing Activities |
202K |
USD |
+36.9% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
350M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
18.2M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
103 |
USD |
|
Q3 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.54M |
USD |
+15.6% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
1.54M |
USD |
+15.6% |
Q3 2024 |
Q1 2025 |
Depreciation |
0 |
USD |
-100% |
Q3 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
534K |
USD |
+2.89% |
Q2 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
7.02M |
USD |
|
Q2 2024 |
FY 2024 |
Additional Paid in Capital |
6.01M |
USD |
+3.2% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
1.43M |
USD |
|
Q1 2024 |
Q3 2024 |
Share-based Payment Arrangement, Expense |
74.9K |
USD |
-46.9% |
Q3 2024 |
Q1 2025 |
Interest Expense |
11.3K |
USD |
+494% |
Q3 2024 |
Q1 2025 |